TFF3 and in situ carcinoma: There was a variable expression of TFF3 by malignant epithelial cells in intraductal carcinoma in situ ranging from absence of any expression (Fig. 3a), to low expression (Fig. 3b), to intermediate expression (Fig. 3c) and high expression (Fig. 3d).